74 related articles for article (PubMed ID: 19948974)
21. Soluble Flt-1 links microvascular disease with heart failure in CKD.
Di Marco GS; Kentrup D; Reuter S; Mayer AB; Golle L; Tiemann K; Fobker M; Engelbertz C; Breithardt G; Brand E; Reinecke H; Pavenstädt H; Brand M
Basic Res Cardiol; 2015 May; 110(3):30. PubMed ID: 25893874
[TBL] [Abstract][Full Text] [Related]
22. PlGF and sFlt-1 levels in patients with non-transfusion-dependent thalassemia: Correlations with markers of iron burden and endothelial dysfunction.
Kelaidi C; Kattamis A; Apostolakou F; Poziopoulos C; Lazaropoulou C; Delaporta P; Kanavaki I; Papassotiriou I
Eur J Haematol; 2018 Jun; 100(6):630-635. PubMed ID: 29543340
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular effects of uremia in apolipoprotein E-deficient mice.
Bro S
Dan Med Bull; 2009 Nov; 56(4):177-92. PubMed ID: 19939336
[TBL] [Abstract][Full Text] [Related]
24. Selective cathepsin S inhibition attenuates atherosclerosis in apolipoprotein E-deficient mice with chronic renal disease.
Figueiredo JL; Aikawa M; Zheng C; Aaron J; Lax L; Libby P; de Lima Filho JL; Gruener S; Fingerle J; Haap W; Hartmann G; Aikawa E
Am J Pathol; 2015 Apr; 185(4):1156-66. PubMed ID: 25680278
[TBL] [Abstract][Full Text] [Related]
25. Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease.
Ataga KI; Brittain JE; Jones SK; May R; Delaney J; Strayhorn D; Desai P; Redding-Lallinger R; Key NS; Orringer EP
Br J Haematol; 2011 Feb; 152(4):485-91. PubMed ID: 21223248
[TBL] [Abstract][Full Text] [Related]
26. Relationship between urinary albumin and serum soluble fms-like tyrosine kinase 1 (sFlt-1) in normal pregnancy.
Yoshimatsu J; Matsumoto H; Goto K; Shimano M; Narahara H; Miyakawa I
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):204-8. PubMed ID: 16426725
[TBL] [Abstract][Full Text] [Related]
27. Sflt-1 in heart failure: relation with disease severity and biomarkers.
Gruson D; Hermans MP; Ferracin B; Ahn SA; Rousseau MF
Scand J Clin Lab Invest; 2016 Sep; 76(5):411-6. PubMed ID: 27291567
[TBL] [Abstract][Full Text] [Related]
28. Damage of the endothelial glycocalyx in chronic kidney disease.
Padberg JS; Wiesinger A; di Marco GS; Reuter S; Grabner A; Kentrup D; Lukasz A; Oberleithner H; Pavenstädt H; Brand M; Kümpers P
Atherosclerosis; 2014 Jun; 234(2):335-43. PubMed ID: 24727235
[TBL] [Abstract][Full Text] [Related]
29. Angiogenic Factors and Risks of Technique Failure and Cardiovascular Events in Patients Receiving Peritoneal Dialysis.
Matsui M; Samejima K; Takeda Y; Morimoto K; Tagawa M; Onoue K; Okayama S; Kawata H; Kawakami R; Akai Y; Okura H; Saito Y
Cardiorenal Med; 2016 May; 6(3):251-9. PubMed ID: 27275161
[TBL] [Abstract][Full Text] [Related]
30. The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD.
Di Marco GS; Reuter S; Hillebrand U; Amler S; König M; Larger E; Oberleithner H; Brand E; Pavenstädt H; Brand M
J Am Soc Nephrol; 2009 Oct; 20(10):2235-45. PubMed ID: 19608702
[TBL] [Abstract][Full Text] [Related]
31. Soluble Fms-like tyrosine kinase-1 (sFlt-1) is associated with subclinical and clinical atherosclerotic cardiovascular disease: The Dallas Heart Study.
Mauricio R; Singh K; Sanghavi M; Ayers CR; Rohatgi A; Vongpatanasin W; de Lemos JA; Khera A
Atherosclerosis; 2022 Apr; 346():46-52. PubMed ID: 35276530
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia-Mediated Soluble Fms-Like Tyrosine Kinase 1 Increase Is Not Attenuated in Interleukin 6-Deficient Mice.
Appel S; Turnwald EM; Ankerne J; Wohlfarth M; Appel J; Rother E; Janoschek R; Alejandre Alcazar MA; Schnare M; Meißner U; Dötsch J
Reprod Sci; 2015 Jun; 22(6):735-42. PubMed ID: 25415335
[TBL] [Abstract][Full Text] [Related]
33. Serum Soluble Fms-Like Tyrosine Kinase 1 (sFlt-1) Predicts the Severity of Acute Pancreatitis.
Dumnicka P; Sporek M; Mazur-Laskowska M; Ceranowicz P; Kuźniewski M; Drożdż R; Ambroży T; Olszanecki R; Kuśnierz-Cabala B
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27929426
[TBL] [Abstract][Full Text] [Related]
34. The Soluble Fms-like Tyrosine Kinase-1 Contributes to Structural and Functional Changes in Endothelial Cells in Chronic Kidney Disease.
Schulz A; Drost CC; Hesse B; Beul K; Brand M; Di Marco GS
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555698
[TBL] [Abstract][Full Text] [Related]
35. Suppression of Development of Ankylosing Spondylitis Through Soluble Flt-1.
Yu Z; Zhang Y; Gao N; Yong K
Cell Physiol Biochem; 2015; 37(6):2135-42. PubMed ID: 26600037
[TBL] [Abstract][Full Text] [Related]
36. Persistently elevated sFlt-1 and recovery of reduced ADAMTS13 activity in malignant hypertension.
Ma H; Wang C; Jiang M; Jin K; Xu T; Wang Z; Xu J; Ni L; Shi H; Shen P; Chen Y; Feng X; Zhang W
J Hypertens; 2024 Mar; 42(3):410-419. PubMed ID: 37889602
[TBL] [Abstract][Full Text] [Related]
37. Association of sFlt-1 and worsening psychopathology in relatives at high risk for psychosis: A longitudinal study.
Lizano PL; Yao JK; Tandon N; Mothi SS; Montrose DM; Keshavan MS
Schizophr Res; 2017 May; 183():75-81. PubMed ID: 27863935
[TBL] [Abstract][Full Text] [Related]
38. Excess Soluble fms-like Tyrosine Kinase 1 Correlates With Endothelial Dysfunction and Organ Failure in Critically Ill Coronavirus Disease 2019 Patients.
Dupont V; Kanagaratnam L; Goury A; Poitevin G; Bard M; Julien G; Bonnivard M; Champenois V; Noel V; Mourvillier B; Nguyen P
Clin Infect Dis; 2021 May; 72(10):1834-1837. PubMed ID: 32672790
[TBL] [Abstract][Full Text] [Related]
39. Soluble fms-like tyrosine kinase-1 – a novel marker for atherosclerotic progression? –.
Pamukcu B; Shantsila E; Lip GY
Circ J; 2010 Oct; 74(10):2064-5. PubMed ID: 20838011
[No Abstract] [Full Text] [Related]
40. Prior Exposure to Experimental Preeclampsia Increases Atherosclerotic Plaque Inflammation in Atherogenic Mice-Brief Report.
Biwer LA; Man JJ; Camarda ND; Carvajal BV; Karumanchi SA; Jaffe IZ
Arterioscler Thromb Vasc Biol; 2024 Apr; 44(4):946-953. PubMed ID: 38450510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
